SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-076515
Filing Date
2023-09-14
Accepted
2023-09-14 09:11:03
Documents
14
Period of Report
2023-09-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea185161-8k_pasithea.htm   iXBRL 8-K 30436
2 PRESS RELEASE OF PASITHEA THERAPEUTICS CORP. ISSUED SEPTEMBER 14, 2023 ea185161ex99-1_pasithea.htm EX-99.1 13465
  Complete submission text file 0001213900-23-076515.txt   267810

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ktta-20230914.xsd EX-101.SCH 3810
4 XBRL DEFINITION FILE ktta-20230914_def.xml EX-101.DEF 26681
5 XBRL LABEL FILE ktta-20230914_lab.xml EX-101.LAB 36819
6 XBRL PRESENTATION FILE ktta-20230914_pre.xml EX-101.PRE 25305
8 EXTRACTED XBRL INSTANCE DOCUMENT ea185161-8k_pasithea_htm.xml XML 5433
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40804 | Film No.: 231254143
SIC: 2834 Pharmaceutical Preparations